Equity Overview
Price & Market Data
Price: $260.7
Daily Change: +$1.33 / 0.51%
Range: $258.8 - $262.8
Market Cap: $18,308,644,864
Volume: 463,617
Performance Metrics
1 Week: 5.64%
1 Month: -1.57%
3 Months: -7.01%
6 Months: 10.19%
1 Year: 55.86%
YTD: -0.14%
Company Details
Employees: 3900
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.